(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.30%) $79.19
(0.10%) $2.04
(0.14%) $2 312.80
(0.25%) $26.90
(0.05%) $963.10
(-0.03%) $0.932
(-0.10%) $10.98
(-0.08%) $0.797
(-0.01%) $91.11
Quarter results today
(amc 2024-05-02)
Expected move: +/- 6.03%
@ $2.25
Išleistas: 14 vas. 2024 @ 16:30
Grąža: -21.78%
Ankstesnis signalas: vas. 13 - 21:04
Ankstesnis signalas:
Grąža: 5.14 %
Live Chart Being Loaded With Signals
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety...
Stats | |
---|---|
Šios dienos apimtis | 871 632 |
Vidutinė apimtis | 1.58M |
Rinkos kapitalizacija | 319.06M |
EPS | $0 ( 2024-03-05 ) |
Kita pelno data | ( $-0.0500 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.38 |
ATR14 | $0.00700 (0.40%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Green Kevin Dennis | Buy | 21 666 | Common Stock |
2024-03-13 | Green Kevin Dennis | Sell | 21 058 | Common Stock |
2024-03-14 | Green Kevin Dennis | Sell | 21 497 | Common Stock |
2024-03-12 | Green Kevin Dennis | Sell | 21 666 | Restricted Stock Unit |
2024-03-12 | Moore Carol | Buy | 11 666 | Common Stock |
INSIDER POWER |
---|
53.72 |
Last 100 transactions |
Buy: 4 007 373 | Sell: 1 157 608 |
Tūris Koreliacija
Cerus Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RGCO | 0.924 |
DCRC | 0.918 |
ASPS | 0.912 |
VIEW | 0.904 |
TIGR | 0.903 |
LGHL | 0.903 |
SFIX | 0.899 |
VIASP | 0.898 |
OP | 0.897 |
LKFN | 0.895 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
ARIZ | -0.918 |
PEP | -0.916 |
LBPH | -0.915 |
TWCB | -0.911 |
GLLI | -0.91 |
XPDB | -0.909 |
AVAC | -0.909 |
HWEL | -0.904 |
MDLZ | -0.903 |
PUCK | -0.901 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cerus Corp Koreliacija - Valiuta/Žaliavos
Cerus Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $156.37M |
Bruto pelnas: | $84.00M (53.72 %) |
EPS: | $-0.210 |
FY | 2023 |
Pajamos: | $156.37M |
Bruto pelnas: | $84.00M (53.72 %) |
EPS: | $-0.210 |
FY | 2022 |
Pajamos: | $162.05M |
Bruto pelnas: | $87.09M (53.75 %) |
EPS: | $-0.240 |
FY | 2021 |
Pajamos: | $159.52M |
Bruto pelnas: | $96.04M (60.21 %) |
EPS: | $-0.316 |
Financial Reports:
No articles found.
Cerus Corp
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.